company background image
SBI logo

Sourcebio International AIM:SBI Stock Report

Last Price

UK£1.15

Market Cap

UK£85.3m

7D

9.5%

1Y

-32.4%

Updated

31 Dec, 2022

Data

Company Financials +

Sourcebio International Plc

AIM:SBI Stock Report

Market Cap: UK£85.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

SBI Stock Overview

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally.

SBI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Sourcebio International Plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sourcebio International
Historical stock prices
Current Share PriceUK£1.15
52 Week HighUK£1.70
52 Week LowUK£0.90
Beta0.024
1 Month Change2.22%
3 Month Change-8.00%
1 Year Change-32.35%
3 Year Changen/a
5 Year Changen/a
Change since IPO-32.75%

Recent News & Updates

Calculating The Fair Value Of Sourcebio International Plc (LON:SBI)

Oct 25
Calculating The Fair Value Of Sourcebio International Plc (LON:SBI)

Recent updates

Calculating The Fair Value Of Sourcebio International Plc (LON:SBI)

Oct 25
Calculating The Fair Value Of Sourcebio International Plc (LON:SBI)

Investors Shouldn't Be Too Comfortable With Sourcebio International's (LON:SBI) Robust Earnings

Oct 05
Investors Shouldn't Be Too Comfortable With Sourcebio International's (LON:SBI) Robust Earnings

Shareholder Returns

SBIGB HealthcareGB Market
7D9.5%0.5%2.2%
1Y-32.4%-21.8%3.7%

Return vs Industry: SBI underperformed the UK Healthcare industry which returned 3.2% over the past year.

Return vs Market: SBI underperformed the UK Market which returned -7.7% over the past year.

Price Volatility

Is SBI's price volatile compared to industry and market?
SBI volatility
SBI Average Weekly Movement5.2%
Healthcare Industry Average Movement7.6%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: SBI has not had significant price volatility in the past 3 months.

Volatility Over Time: SBI's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1999339n/ahttps://sourcebiointernational.com

Sourcebio International Plc, together with its subsidiaries, provides various laboratory services and products to clients in the healthcare, clinical, life science research, and biopharma industries in the United Kingdom, Europe, the United States, and internationally. The company’s services cover histopathology cancer screening and clinical diagnostic services; DNA sequencing services and precision medicine to pharmaceutical and biotechnology companies, academia, contract research organizations, and other research markets; shelf-life testing services and equipment; and COVID-19 antigen PCR testing services. It also manufactures library clones, direct to consumer home test kits, and blood and tissue serological products; and provides employee testing solutions and venue testing.

Sourcebio International Plc Fundamentals Summary

How do Sourcebio International's earnings and revenue compare to its market cap?
SBI fundamental statistics
Market capUK£85.31m
Earnings (TTM)UK£6.69m
Revenue (TTM)UK£75.61m

12.7x

P/E Ratio

1.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SBI income statement (TTM)
RevenueUK£75.61m
Cost of RevenueUK£48.44m
Gross ProfitUK£27.18m
Other ExpensesUK£20.48m
EarningsUK£6.69m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.09
Gross Margin35.94%
Net Profit Margin8.85%
Debt/Equity Ratio0%

How did SBI perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.